Fund Holdings — ORACLE INVESTMENT MANAGEMENT INC

Total Portfolio Value
$153.60M
Total Bought
$20.93M
Total Sold
$29.00M
Net Transaction
-$8.07M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
SPRINGWORKS THERAPEUTICS INC254,773531,351+276,5789,20523,44915.27%+14,244
GENEDX HOLDINGS CORP(WGS)1,023,468969,954-53,51478,66485,90455.93%+7,240
TELADOC HEALTH INC(TDOC)0565,900+565,90004,5052.93%+4,505
ARDELYX INC2,089,4312,404,438+315,00710,59311,8067.69%+1,212
RECURSION PHARMACEUTICALS IN(RXRX)0120,000+120,00006350.41%+635
PALANTIR TECHNOLOGIES INC(PLTR)28,50029,500+1,0002,1552,4901.62%+334
BIOGEN INC(BIIB)2,4122,41203693300.21%-39
FORIAN INC
COM
1,366,1071,366,10702,8142,7321.78%-82
EYEPOINT PHARMACEUTICALS INC(EYPT)32,5000-32,5002420—-242
CAVA GROUP INC(CAVA)18,60018,60002,0981,6071.05%-491
PACIFIC BIOSCIENCES CALIF IN(PACB)279,6380-279,6385120—-512
QUIDELORTHO CORP(QDEL)118,291118,29105,2704,1372.69%-1,133
PHATHOM PHARMACEUTICALS INC(PHAT)145,0640-145,0641,1780—-1,178
BIOCRYST PHARMACEUTICALS INC(BCRX)535,5580-535,5584,0270—-4,027
BIOHAVEN LTD(BHVN)851,770665,945-185,82531,81416,00910.42%-15,804
Page 1 of 1